Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Minden

Showing results (51-60 of 308) with videos related to

Pageof 31
Sort By:
Apoptosis : an International Journal on Programmed Cell Death|May 23, 2015
Carnitine transporter CT2 (SLC22A16) is over-expressed in acute myeloid leukemia (AML) and target knockdown reduces growth and viability of AML cellsYan Wu, Rose Hurren, Neil MacLean, et al.
Biochemical and Biophysical Research Communications|August 21, 2003
NKIAMRE, a novel conserved CDC2-related kinase with features of both mitogen-activated protein kinases and cyclin-dependent kinasesKaren W L Yee, Susan J Moore, Michael Midmer, et al.
Human Pathology|August 18, 2020
Acute myeloid leukemia with myelodysplasia-related changes diagnosed with multilineage dysplasia alone demonstrates a superior clinical outcomeGina Jiang, Jose-Mario Capo-Chichi, Aijun Liu, et al.
British Journal of Haematology|August 28, 2014
Phase II study of targeted therapy with temozolomide in acute myeloid leukaemia and high-risk myelodysplastic syndrome patients pre-screened for low O(6) -methylguanine DNA methyltransferase expressionJoseph M Brandwein, Jeannine Kassis, Brian Leber, et al.
Canadian Respiratory Journal|July 23, 2016
Outcomes and Predictors of Mortality for Patients with Acute Leukemia Admitted to the Intensive Care UnitAlan P Kraguljac, Danielle Croucher, Michael Christian, et al.
Critical Reviews in Oncology/Hematology|September 10, 2008
Quality of life beyond 6 months after diagnosis in older adults with acute myeloid leukemiaShabbir M H Alibhai, Marc Leach, Vikas Gupta, et al.
Plos One|February 8, 2018
SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AMLIrakli Dzneladze, John F Woolley, Carla Rossell, et al.
Blood|February 26, 2026
Targeting ABCD1 inhibits peroxisomal fatty acid oxidation to selectively eliminate acute myeloid leukemia cellsEkaterina N Parfenova, Nikolina Vrdoljak, Drake Mosca, et al.
Journal for Immunotherapy of Cancer|April 17, 2025
Single-cell RNA sequencing of human double-negative T cells reveals a favorable cellular signature for cancer therapyEnoch Tin, Ismat Khatri, Karen Fang, et al.
Leukemia & Lymphoma|October 15, 2016
Incidence rates of treatment-emergent adverse events and related hospitalization are reduced with azacitidine compared with conventional care regimens in older patients with acute myeloid leukemiaJohn F Seymour, Hartmut Döhner, Mark D Minden, et al.
Pageof 31

Showing results (51-60 of 308) with videos related to

Sort By:
Pageof 31
Apoptosis : an International Journal on Programmed Cell Death|May 23, 2015
Carnitine transporter CT2 (SLC22A16) is over-expressed in acute myeloid leukemia (AML) and target knockdown reduces growth and viability of AML cellsYan Wu, Rose Hurren, Neil MacLean, et al.
Biochemical and Biophysical Research Communications|August 21, 2003
NKIAMRE, a novel conserved CDC2-related kinase with features of both mitogen-activated protein kinases and cyclin-dependent kinasesKaren W L Yee, Susan J Moore, Michael Midmer, et al.
Human Pathology|August 18, 2020
Acute myeloid leukemia with myelodysplasia-related changes diagnosed with multilineage dysplasia alone demonstrates a superior clinical outcomeGina Jiang, Jose-Mario Capo-Chichi, Aijun Liu, et al.
British Journal of Haematology|August 28, 2014
Phase II study of targeted therapy with temozolomide in acute myeloid leukaemia and high-risk myelodysplastic syndrome patients pre-screened for low O(6) -methylguanine DNA methyltransferase expressionJoseph M Brandwein, Jeannine Kassis, Brian Leber, et al.
Canadian Respiratory Journal|July 23, 2016
Outcomes and Predictors of Mortality for Patients with Acute Leukemia Admitted to the Intensive Care UnitAlan P Kraguljac, Danielle Croucher, Michael Christian, et al.
Critical Reviews in Oncology/Hematology|September 10, 2008
Quality of life beyond 6 months after diagnosis in older adults with acute myeloid leukemiaShabbir M H Alibhai, Marc Leach, Vikas Gupta, et al.
Plos One|February 8, 2018
SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AMLIrakli Dzneladze, John F Woolley, Carla Rossell, et al.
Blood|February 26, 2026
Targeting ABCD1 inhibits peroxisomal fatty acid oxidation to selectively eliminate acute myeloid leukemia cellsEkaterina N Parfenova, Nikolina Vrdoljak, Drake Mosca, et al.
Journal for Immunotherapy of Cancer|April 17, 2025
Single-cell RNA sequencing of human double-negative T cells reveals a favorable cellular signature for cancer therapyEnoch Tin, Ismat Khatri, Karen Fang, et al.
Leukemia & Lymphoma|October 15, 2016
Incidence rates of treatment-emergent adverse events and related hospitalization are reduced with azacitidine compared with conventional care regimens in older patients with acute myeloid leukemiaJohn F Seymour, Hartmut Döhner, Mark D Minden, et al.
Pageof 31